PRRG2 Antibody [Dylight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-46873G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
proline rich Gla(G-carboxyglutamic acid) 2. (Uniprot# O14669)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for PRRG2 Antibody [Dylight 488]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PRRG2
Alternate Names
PRGP2proline-rich Gla (G-carboxglutamic acid) polypeptide 2, proline rich Gla (G-carboxyglutamic acid) 2, Proline-rich gamma-carboxyglutamic acid protein 2, proline-rich Gla (G-carboxyglutamic acid) polypeptide 2, Proline-rich Gla protein 2, TMG2, transmembrane gamma-carboxyglutamic acid protein 2
Gene Symbol
PRRG2
Additional PRRG2 Products
Product Documents for PRRG2 Antibody [Dylight 488]
Product Specific Notices for PRRG2 Antibody [Dylight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...